Clinical Trials

Chemoembolisation Using Doxorubicin in Treating Patients with Liver Cancer That Cannot be removed by Surgery

• This clinical trial is studying how well chemoembolisation using doxorubicin works in treating patients with liver cancer that cannot be removed by surgery.

Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolisation using Bead Block™ Embolic Agent

• A double arm (non-inferiority) 44 patient study to assess the performance of Bead Block in the treatment of uterine fibroids by embolisation with respect to clinical and imaging outcome with comparison of primary safety endpoints to Embosphere.

Doxorubicin with or without Chemoembolisation in Treating Patients with Advanced Unresectable Hepatocellular carcinoma (Liver Cancer)

• This randomised phase III trial is studying doxorubicin alone to see how well it works compared to doxorubicin and chemoembolisation in treating patients with advanced liver cancer that cannot be removed by surgery.

Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Systemic FOLFOX6

• This is a multicentre, open labeled, controlled phase study designed to assess effectiveness of chemoembolization with LC Beads, both with and without systemic chemotherapy, in the treatment of unresectable liver metastases in patients with colorectal cancer.

LC Drug Eluting Bead for Treatment of Liver Cancer Which Cannot be Surgically Removed (HCC)

• Advanced HCC represents a high unmet medical need with a poor prognosis and few therapeutic options. Patients who present with HCC beyond the currently accepted Milan criteria are not eligible to be listed for liver transplantation. The proposed study offers local regional therapy to a defined population of patients beyond Milan criteria as an attempt to downstage them to eligibility for liver transplant.

Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Embolisation (PRECISION V)

• The objective of this study is to assess the safety and efficacy of DC Bead™ delivered by intra-arterial embolisation for the treatment of Hepatocellular Carcinoma.

Study of Chemoembolisation Using Irinotecan Bead Prior to Surgery in Metastatic Colorectal Cancer (PARAGON-II)

• The objective of this study is to evaluate the safety and efficacy of Irinotecan Bead in the neoadjuvant treatment (i.e. the Irinotecan Bead is administered prior to surgery) of resectable liver metastases from colorectal cancer.

To view our Drug-Eluting Bead Technology Clincial Trials, please click here

 

---

In this section

---

Search

Search
Advanced Search